Marina Morla-González

Dr. Marina Morla-González


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Journal of Law and the Biosciences
Verified
Journal Article
Open access
PDF file
IBINIGO DE MIGUEL BERIAIN
INIGO DE MIGUEL BERIAIN
MMMarina Morla-González
Marina Morla-González
Recently, the US Food and Drug Administration has given a landmark approval to the very first digital pill with a sensor embedded in the inside. These are complex systems that include a drug and an electronic tracker that is activated when the patient takes the pill. Accordingly, they might be an excellent tool for monitoring and potentially improving patients’ adherence to prescriptions. This would serve well to avoid unnecessary healthcare costs and reduce the anxiety of patients and their relatives. However, digital pills might also diminish patient autonomy, reduce privacy, or promote inadequate use of pharmaceutical resources. This article is aimed at contributing to adequate use of this new tool by showing the main ethical and social issues they involve and proposing measures meant to address them. Finally, we conclude by defending the idea that these new systems should be seen as means of complementing traditional strategies to promote adherence to treatment, and not as substitutes.

27 April 2021 in Clinical Ethics
Verified
Journal Article
Closed access
PDF file
MMMarina Morla-González
Marina Morla-González
CMClara Moya-Guillem
Clara Moya-Guillem
DRDavid Rodríguez-Arias
David Rodríguez-Arias
ÍBÍñigo de Miguel Beriain
Íñigo de Miguel Beriain
AMAlberto Molina-Pérez
Alberto Molina-Pérez
IOIván Ortega-Deballon
Iván Ortega-Deballon
Organ shortage constitutes an unsolved problem for every country that offers transplantation as a therapeutic option. Besides the largely implemented donation model and the eventually implemented market model, a theorized automatic organ procurement model has raised a rich debate in the legal, medical and bioethical community, since it could show a higher potential to solve organ shortage. In this paper, we study the main arguments for and against this model. We show how, in the light of empirical data extracted from countries with a universal health care system, its implementation could lead to a positive impact on organ procurement rates. Three factors are envisioned as fundamental in the comprehension and a possible regulation of the automatic organ procurement model: the lack of recognition of the conscientious objection, the preservation of the right to choose end of life conditions, and the need to avoid incentives for families or healthcare professionals.

1 May 2021 in Revista Española de Derecho Constitucional
Verified
Journal Article
Closed access
CGClara Moya Guillem
Clara Moya Guillem
DRDavid Rodriguez-Arias
David Rodriguez-Arias
MMMarina Morla-González
Marina Morla-González
ÍBÍñigo de Miguel Beriain
Íñigo de Miguel Beriain
Alberto Molina-PérezAlberto Molina-Pérez
Alberto Molina-Pérez
IOIván Ortega-Deballon
Iván Ortega-Deballon
This paper analyses the arguments for and against what we have called automatic organ procurement model in relation to the organs of the deceased. For this purpose, this work provides empirical evidence to assess the potential impact of this model on donation rates and on public opinion. Specifically, we examine first the reasons supporting this model, with special reference to utilitarian and justice arguments. On the other hand, we analyse both the approaches based on the violation of pre mortem and post mortem interests opposing this theoretical model and the rejection the model would generate in the population. Finally, we point out the aspects that, in our opinion, should be exhaustively regulated if this model were implemented. In particular, we refer to the legal status of the human body, the treatments for end-of-life patients, the incentives for health professionals and the recognition of the right to conscientious objection

21 October 2025 in Revista de Bioética y Derecho
Verified
Journal Article
Open access
PDF file
MMMarina Morla-González
Marina Morla-González
The Internet of Things (IoT) is revolutionizing precision medicine and patient care by enabling connectivity between treatments with integrated technology and the healthcare professional. The pharmaceutical industry views IoT as an opportunity for innovation and profit, particularly as drug patents expire. The emergence of Pharma IoT firmly places patients in center of precision medicine, in which pharmaceutical products increasingly integrate digital components. IoT applications in healthcare include smart drug delivery systems, remote monitoring, and real-time data collection, improving patient outcomes and treatment personalization. Despite these advancements, IoT implementation in healthcare raises ethical, legal, and regulatory challenges. This contribution focuses on analysing how such digital therapies affect two fundamental values. Firstly, trust, a pillar on which the care relationship is based. The value of reasonable trust in the care relationship in a context of digitalised medicine will be addressed. Secondly, the principle of autonomy, which informs clinical practice. This section focuses on the imbalances of power and external influences on patient autonomy, the risks and biases inherent in the operation of sophisticated technologies, and the search for a balance between autonomy, transparency and the protection of public health. The conclusion underscores the need to balance technological progress with ethical and legal considerations. While IoT offers promising advancements for personalized medicine, its successful implementation depends on robust regulatory frameworks that protect patient rights while fostering innovation.

29 December 2025 in Revista jurídica de la Universidad de León
Verified
Journal Article
Open access
PDF file
MMMarina Morla-González
Marina Morla-González
Este artículo analiza la violencia obstétrica como una forma de violencia de género y una violación de derechos humanos que se manifiesta durante el embarazo, el parto y el posparto. A partir del informe de la Relatora Especial de Naciones Unidas, se examinan las principales prácticas que configuran este fenómeno y sus causas estructurales, vinculadas a modelos de atención medicalizados, estereotipos de género y desigualdades persistentes. El estudio compara posteriormente la respuesta normativa de México y España, evidenciando dos aproximaciones divergentes: mientras México reconoce explícitamente la violencia obstétrica en su legislación y ha desarrollado marcos específicos de prevención, atención y sanción, España carece aún de un reconocimiento jurídico del concepto y aborda estas vulneraciones desde normas generales sobre autonomía del paciente y derechos sanitarios. A través del análisis de casos emblemáticos resueltos por el Comité CEDAW, se pone de manifiesto la insuficiencia de los mecanismos de garantía en el contexto español. El artículo concluye que, aunque ambos países enfrentan desafíos comunes en la implementación práctica de la atención respetuosa, el reconocimiento conceptual y normativo resulta determinante para visibilizar, medir y erradicar la violencia obstétrica.

21 June 2026 in Religions
Verified
Journal Article
Open access
PDF file
MMMarina Morla-González
Marina Morla-González
The legalization of euthanasia in Spain through Organic Law 3/2021 has intensified debates concerning the relationship between patients’ autonomy, the protection of life, and the freedom of conscience of healthcare professionals. In a context marked by increasing moral and religious pluralism, conscientious objection has emerged as a particularly sensitive issue in the practical implementation of assisted dying. This article adopts a legal and socio-religious approach to analyze the role of conscientious objection in the Spanish euthanasia framework. First, it examines the constitutional foundations of freedom of conscience and its specific regulation under Organic Law 3/2021, with particular attention to the guarantees and limits established for healthcare professionals. Second, it analyses the official positions of the main religious traditions present in Spain regarding euthanasia, assisted suicide, and end-of-life care, identifying both points of convergence and doctrinal diversity. Finally, the article assesses the practical impact of religious and moral convictions on the exercise of conscientious objection, drawing on the limited empirical evidence currently available. The analysis shows that, although most religious traditions oppose active euthanasia while accepting palliative care and the withdrawal of futile treatments, analysis of available empirical evidence suggests that objections are more often grounded in secular ethical or professional reasons than explicitly religious ones. The article concludes that conscientious objection should be understood as a structural feature of pluralist healthcare systems, requiring legal and organizational arrangements capable of safeguarding both freedom of conscience and effective access to legally recognized rights.